Details for 2017841107

Up to date per 01.04.2026

Actions

Title / Product Name

KOMBINATION VON ZANUBRUTINIB MIT EINEM ANTI-CD20 ODER ANTI-PD-1 ANTIKÖRPER ZUR VERWENDUNG IN DER BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017841107

EP Publication Number

3500299

E-Number

1639924

Language

PCT Number

CN17098023

Publication Date

26.06.2019 A

13.12.2023 B1

Registration Date

13.12.2023

AT Publication Date

15.01.2024

Application Date

18.08.2017

Registration Number

Priorities

19.08.2016

PCT/CN2016/096082

IPC

A61K 39/395 20060101AFI20200217BHEP

Maximum Duration of Protection

18.08.2037

Owner

Beigene Switzerland GmbHAeschengraben 27 4051 BaselCH

Representative

No representatives present

Inventor

HU, NanNo.30 Science Park Road Zhongguancun Life Science Park Changping Beijing 102206CN

WANG, LaiNo.30 Science Park Road Zhongguancun Life Science Park Changping Beijing 102206CN

SONG, JingNo.30 Science Park Road Zhongguancun Life Science Park Changping Beijing 102206CN

ZHANG, TongNo.30 Science Park Road Zhongguancun Life Science Park Changping Beijing 102206CN

LI, KangNo.30 Science Park Road Zhongguancun Life Science Park Changping Beijing 102206CN

LUO, LusongNo.30 Science Park Road Zhongguancun Life Science Park Changping Beijing 102206CN

WEI, MinNo.30 Science Park Road Zhongguancun Life Science Park Changping Beijing 102206CN

WANG, ZhiweiNo.30 Science Park Road Zhongguancun Life Science Park Changping Beijing 102206CN

GUO, YunhangNo.30 Science Park Road Zhongguancun Life Science Park Changping Beijing 102206CN

Information about Fees